Format

Send to

Choose Destination
BMJ Case Rep. 2012 Nov 14;2012. pii: bcr2012006413. doi: 10.1136/bcr-2012-006413.

Bezafibrate to prevent relapsing pancreatitis in WAGR syndrome.

Author information

1
Department of Paediatric Endocrinology, Royal Manchester Children's Hospital, Manchester, UK.

Abstract

Recurrent episodes of acute, severe pancreatitis are a feature of the rare WAGR congenital anomaly syndrome. Although pancreatitis is well recognised as a life-threatening association of WAGR syndrome, treatment to prevent pancreatitis is not recommended. We report the successful prevention of hypertriglyceridaemia-associated relapsing pancreatitis in a child with WAGR syndrome with Bezafibrate. In addition to dietary fat restriction, Bezafibrate may be a useful therapeutic adjunct in WAGR related relapsing pancreatitis.

PMID:
23152176
PMCID:
PMC4543478
DOI:
10.1136/bcr-2012-006413
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center